文献速递肿瘤 PET/CT

国际预后指数在移植后淋巴增殖性疾病中的预后价值优于[18F]FDG PET/CT体积参数

Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder.
PubMed 文献 · EJNMMI Res · 2021-03-18

本研究回顾性纳入88例移植后淋巴增殖性疾病(PTLD)患者,评估[18F]FDG PET/CT全身代谢肿瘤体积(MTV)和总病灶糖酵解(TLG)等体积参数的预后价值。多变量分析显示高国际预后指数(IPI)和EBV阴性肿瘤与较差总生存相关,而MTV、TLG等体积参数与总生存无关。

要点

  • 高IPI(HR 1.56,95%CI 1.13-2.16)和EBV阴性肿瘤(HR 2.71,95%CI 1.38-5.32)与较差总生存相关。
  • [18F]FDG PET/CT全身MTV和TLG未显示对总生存的预测价值。
  • 肾移植患者总生存优于其他器官移植受者(HR 0.38,95%CI 0.16-0.89)。

核心结论

  • [18F]FDG PET/CT全身体积定量参数不能预测PTLD患者的总生存。
  • 高IPI和EBV阴性肿瘤是较差总生存的预测因素。
  • 肾移植患者总生存优于其他器官移植受者。

研究设计与样本

  • 回顾性研究,纳入88例移植后淋巴增殖性疾病(PTLD)患者。
  • 评估[18F]FDG PET/CT体积参数(MTV、TLG)及其他变量(IPI、移植类型、EBV状态、移植后时间、白蛋白、PTLD形态)的预后价值。

主要发现

  • 1年、3年、5年总生存率分别为67%、58%和43%。
  • 多变量分析显示高IPI(HR 1.56,95%CI 1.13-2.16)和EBV阴性肿瘤(HR 2.71,95%CI 1.38-5.32)与较差总生存相关。
  • 肾移植患者总生存优于其他器官移植受者(HR 0.38,95%CI 0.16-0.89)。
  • 全身MTV、TLG、移植后时间、低白蛋白血症和PTLD形态与总生存无关。

关键数值与推荐

  • IPI在本队列中被发现是总生存的最佳预测参数。

临床怎么用

  • 在PTLD患者中,IPI和EBV状态可用于预后分层,而[18F]FDG PET/CT体积参数不应作为常规预后工具。
  • 肾移植受者较其他器官移植受者预后更好,可考虑在临床评估中关注移植类型。

局限性

  • 回顾性研究设计。
  • 样本量有限(88例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-transplant lymphoproliferative disorders (PTLDs) are a spectrum of hematological malignancies occurring after solid organ and hematopoietic stem cell transplantation. [18F]FDG PET/CT is routinely performed at PTLD diagnosis, allowing for both staging of the disease and quantification of volumetric parameters, such as whole-body metabolic tumor volume (MTV) and total lesion glycolysis (TLG). In this retrospective study, we aimed to determine the prognostic value of MTV and TLG in PTLD patients, together with other variables of interest, such as the International Prognostic Index (IPI), organ transplant type, EBV tumor status, time after transplant, albumin levels and PTLD morphology. RESULTS: A total of 88 patients were included. The 1-, 3-, 5- year overall survival rates were 67%, 58% and 43% respectively. Multivariable analysis indicated that a high IPI (HR: 1.56, 95% CI: 1.13-2.16) and an EBV-negative tumor (HR: 2.71, 95% CI: 1.38-5.32) were associated with poor overall survival. Patients with a kidney transplant had a longer overall survival than any other organ recipients (HR: 0.38 95% CI: 0.16-0.89). IPI was found to be the best predicting parameter of overall survival in our cohort. Whole-body MTV, TLG, time after transplant, hypoalbuminemia and PTLD morphology were not associated with overall survival. CONCLUSION: [18F]FDG PET/CT whole-body volumetric quantitative parameters were not predictive of overall survival in PTLD. In our cohort, high IPI and an EBV-negative tumor were found to predictors of worse overall survival while kidney transplant patients had a longer overall survival compared to other organ transplant recipients.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Montes de Jesus F, Dierickx D, Vergote V, et al. Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder. EJNMMI Res. 2021. PMID: 33738643. doi:10.1186/s13550-021-00769-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。